Current perspectives on ranibizumab
Vaidehi S Dedania,1 Sophie J Bakri21Department of Ophthalmology, Albany Medical Center, Lions Eye Institute, Albany, NY, USA; 2Department of Ophthalmology, Mayo Clinic, Rochester, MN, USABackground: This review summarizes the Phase III studies addressing intravitreal ranibizumab treatment in patien...
Guardado en:
Autores principales: | Dedania VS, Bakri SJ |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/095644ceffa5427ba9b3b4bd05e586bc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Diabetic papillopathy with macular edema treated with intravitreal ranibizumab
por: Kim M, et al.
Publicado: (2013) -
Ranibizumab for the treatment of degenerative ocular conditions
por: Triantafylla M, et al.
Publicado: (2014) -
Keratoconus: current perspectives
por: Vazirani J, et al.
Publicado: (2013) -
Single intravitreal ranibizumab for myopic choroidal neovascularization
por: Shatriah I, et al.
Publicado: (2011) -
Ocular tuberculosis: current perspectives
por: Shakarchi FI
Publicado: (2015)